These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7841589)

  • 21. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
    Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
    Vrabel M
    Clin J Oncol Nurs; 2007 Dec; 11(6):809-13. PubMed ID: 18063539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ondansetron: a new entity in emesis control.
    Graves T
    DICP; 1990 Nov; 24(11 Suppl):S51-4. PubMed ID: 2148659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of ondansetron in radiation-induced nausea and vomiting: review of the literature].
    Lévy E; Paillarse JM; Votan B
    Bull Cancer Radiother; 1994; 81(3):179-85. PubMed ID: 7702901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
    Navari RM; Madajewicz S; Anderson N; Tchekmedyian NS; Whaley W; Garewal H; Beck TM; Chang AY; Greenberg B; Caldwell KC
    J Clin Oncol; 1995 Sep; 13(9):2408-16. PubMed ID: 7666101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ondansetron HCL (Zofran TM, Glaxo).
    Frankiewicz V; Farrington E
    Pediatr Nurs; 1992; 18(4):385-6. PubMed ID: 1387704
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
    Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
    Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the efficacy of anti-emetic therapy with ondansetron injected intravenously at a daily dose of 8mg (analysis of material)].
    Cieślińska A; Pajak K; Ziemba AB; Filipczyk-Cisarz E; Gajewska A
    Pol Merkur Lekarski; 1996 Nov; 1(5):337-9. PubMed ID: 9273212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron for symptomatic relief in terminal uraemia.
    Andrews PA; Quan V; Ogg CS
    Nephrol Dial Transplant; 1995; 10(1):140. PubMed ID: 7724017
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
    Kaushal J; Gupta MC; Kaushal V; Bhutani G; Dhankar R; Atri R; Verma S
    Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ondansetron in the treatment of postoperative nausea and vomiting in ambulatory outpatients: a dose-comparative, stratified, multicentre study.
    Du Pen S; Scuderi P; Wetchler B; Sung YF; Mingus M; Clayborn L; Leslie J; Talke P; Apfelbaum J; Sharifi-Azad S
    Eur J Anaesthesiol Suppl; 1992 Nov; 6():55-62. PubMed ID: 1425626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Odansetron.
    Betcher DL; Burnham N
    J Pediatr Oncol Nurs; 1991 Oct; 8(4):183-5. PubMed ID: 1834086
    [No Abstract]   [Full Text] [Related]  

  • 40. Zofran: first of a new class of antiemetics.
    Wilson BA
    Medsurg Nurs; 1994 Jun; 3(3):218-9. PubMed ID: 8055040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.